Substituted diarylureas as stimulators for fas-mediated...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 275/42 (2006.01) A61K 31/17 (2006.01) A61P 19/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07C 275/30 (2006.01) C07C 309/65 (2006.01) C07C 317/42 (2006.01)

Patent

CA 2434020

Substituted diarylureas, pharmaceutical compositions containing them, and their use for stimulating Fas-mediated apoptosis. The compounds, as single stereoisomers or mixtures of stereoisomers, their pharmaceutically acceptable salts, and pharmaceutical compositions containing them, are useful in methods of treating autoimmune diseases, infectious diseases, and malignancies.

La présente invention concerne des diarylurées substituées, des compositions pharmaceutiques les contenant et leur utilisation comme stimulateurs de l'apoptose à médiation des Fas. Ces composés, sous forme de stéréoisomères seuls ou mélanges de stéréoisomères, certains de leurs sels pharmaceutiquement admis, ainsi que des compositions pharmaceutiques les contenant, conviennent pour des procédures concernant le traitement d'affections auto-immunes, infectieuses et malignes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted diarylureas as stimulators for fas-mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted diarylureas as stimulators for fas-mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted diarylureas as stimulators for fas-mediated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1777187

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.